EFFECT OF TREATMENT OF GUMS IN PATIENTS WITH GUM DISEASE AND DIABETES
- Conditions
- Health Condition 1: null- Prediabetic patients with chronic periodontitis
- Registration Number
- CTRI/2014/09/004952
- Lead Sponsor
- Dr MEERA S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
1.Patients with age group between 25 to 55.
2.Minimum of 20 teeth present.
3.Patients who were diagnosed with severe periodontitis chronic periodontitis (CDC criteria moderate periodontitis is defind as >=2 interproximal sites with >= 4mm clinical attacment loss (CAL) not on same tooth,or >=2 interproximal with probing depth (PD) >= 5mm not on same tooth severe periodontitis is defind as >=2 teeth with clinical attachment loss >=6mm not on same tooth and >=1 interproximal site with probing depth >= 5mm).
4.pre diabetic patients with Hb A1c 5.7-6.4%
1.Patients with known systemic disease and condition such as CVD, renal disease, RA, diabetes Mellitus, liver and pancreatic disease, nutritional deficiencies, pregnant and lactating mother.
2.Patients with conditions that shorten erythrocyte survival (e.g., hemolytic
anemia, pregnancy, or recent significant blood loss, or who are positive for rheumatoid factors.)
3.Patients with acute condition that contraindicate a periodontal
examination.
4. Patients who received systemic antibiotic therapy within past 6 months.
5. Patients who received periodontal therapy (scaling and root planing or surgery) past 1 year.
6. Patients not willing to sign informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method